A Rare Case of Bilateral Rasmussen’s Encephalitis with Cortical Venous Thrombosis Authors: Swati Gupta, Monika Singh, Mahesh K Lal, Dhrubajit Das, Ayushi Daga Published: 2026 Dear Editor, Rasmussen encephalitis (RE) is a rare chronic inflammatory neurological disorder characterized by drug-resistant focal epilepsy, progressive neurological deficits, and cerebral hemiatrophy. It predominantly affects children and young adults, with an estimated incidence of less than 2.4 per 10 million individuals under 18 years of age.[1] Clinically, RE typically manifests with focal motor seizures that may progress to epilepsia partialis continua (EPC), accompanied by cognitive decline and progressive hemiparesis.[12] Histopathological hallmarks include T-cell-mediated inflammation, microglial activation, and neuronal loss, while neuroimaging classically demonstrates progressive unilateral cortical atrophy with associated T2/FLAIR signal abnormalities.[13] Immunomodulatory therapy, including corticosteroids and intravenous immunoglobulin (IVIG), remains the cornerstone of treatment, whereas hemispherectomy is reserved for selected unilateral cases.[45] Bilateral RE is exceptionally uncommon. By 2013, only 12 cases had been reported, of which merely 2 were confirmed at autopsy.[6] Subsequent reports have increased the number of documented cases to approximately 16 worldwide.[789] The coexistence of RE with cortical venous thrombosis (CVT) has not been previously reported. We describe a rare case of bilateral RE associated with CVT in a young adult. A 25-year-old man with a history of poorly controlled focal seizures since the age of eight years presented with continuous left-sided focal seizures for two days, accompanied by vomiting and altered sensorium. His seizures initially involved the right side of the body and had remained refractory to treatment. During the preceding year, he developed progressive functional dependence and new-onset left-sided seizures, suggesting contralateral cerebral involvement. At presentation, he was in status epilepticus with a Glasgow Coma Scale (GCS) score of E2V1M3. Neurological examination revealed continuous left facial and limb seizures, bilateral extensor plantar responses, and left lateral rectus palsy. Non-contrast computed tomography demonstrated marked left cerebral hemiatrophy and an acute right parietal infarct with hemorrhagic transformation [Figure 1]. Magnetic resonance imaging revealed diffuse right hemispheric gyral edema, a hemorrhagic venous infarct [Figure 2], and subacute superior sagittal sinus thrombosis [Figure 3]. Additionally, marked left cerebral atrophy with crossed right cerebellar atrophy was identified [Figure 4]. These findings were suggestive of bilateral RE with superimposed CVT. Multiple blooming artifacts seen in the right fronto-parietal cor tex and subcor tical region, indicating subacute hemorrhagic venous infarct (Green arrow). Marked left cerebral atrophy (Red arrow) Extensive and diffuse gyral swelling and sulcal effacement involving the right cerebral hemisphere, suggesting right cerebral edema (Red arrow) . Heterogeneous hyperintensity suggestive of hemorrhagic infarct (Green arrow) . Hyperintensity in the right cerebellar hemisphere and architectural distortion on the T2-weighted image—right cerebellar atrophy (Red arrow) Long segment filling defect is seen in the superior sagittal sinus (SSS), suggestive of SSS thrombosis (Red arrow) Hyperintensity in the right cerebellar hemisphere and architectural distortion on the T2-weighted image—right cerebellar atrophy (Green arrow) The diagnosis of RE was established using the clinical and radiological criteria outlined in Part B of the 2005 European Consensus Statement on RE.[10] The patient fulfilled the clinical criterion of focal epilepsy progressing to EPC with progressive neurological deterioration and functional decline. Radiologically, serial imaging demonstrated longstanding left hemispheric atrophy followed by contralateral hemispheric involvement, supporting the diagnosis of bilateral disease evolution. Electroencephalography (EEG) could not be performed because the patient presented in refractory status epilepticus with significant clinical instability, and bedside EEG facilities were unavailable at our institution. This represents an important limitation of the present report. Brain biopsy was considered; however, consent for the procedure could not be obtained. Routine hematological and biochemical investigations were unremarkable. Cerebrospinal fluid analysis revealed a leukocyte count of 2 cells/mm3, a protein concentration of 42 mg/dL, and a glucose concentration of 68 mg/dL, with a corresponding blood glucose level of 108 mg/dL. Microbiological studies were negative, and no evidence of central nervous system infection was identified. A comprehensive thrombophilia workup, including assessment of protein C, protein S, antithrombin III, antiphospholipid antibodies, homocysteine levels, and factor V Leiden mutation screening, was negative. Evaluation for systemic infections and malignancy was also unrevealing. The patient received antiseizure therapy with intravenous levetiracetam (1500 mg twice daily), sodium valproate (1000 mg twice daily), lacosamide (200 mg twice daily), and oral clobazam (10 mg twice daily). Mannitol was administered to reduce cerebral edema. For CVT, anticoagulation was initiated with low-molecular-weight heparin (60 mg twice daily) and subsequently transitioned to apixaban (5 mg twice daily). Immunotherapy was commenced with intravenous methylprednisolone (1 g/day for five days). Owing to inadequate clinical response, IVIG was subsequently administered at a cumulative dose of 120 g over five days. Although EEG confirmation was unavailable, immunotherapy was initiated because of the strong clinical and radiological suspicion of RE, the presence of EPC, progressive neurological deterioration, and fulfillment of established consensus diagnostic criteria.[10] Following treatment, seizure frequency improved and antiepileptic medications were gradually reduced. However, neurological recovery remained limited, with a GCS of E4V1M5 at the time of discharge. At three-month follow-up, seizure burden had decreased substantially, but significant left hemiparesis and cognitive impairment persisted. Bilateral RE is associated with a poorer prognosis than the classic unilateral form because both cerebral hemispheres become progressively involved. In this patient, the transition from longstanding right-sided seizures with left hemispheric atrophy to new-onset left-sided seizures and right hemispheric pathology strongly supported bilateral disease evolution. Similar patterns have been described rarely in the literature.[6789] An additional and unique feature of this case was the coexistence of CVT. MR venography confirmed superior sagittal sinus thrombosis with associated hemorrhagic venous infarction. Although CVT commonly occurs in association with prothrombotic disorders, infection, malignancy, and systemic inflammatory states, none of these factors were identified in our patient. Nevertheless, caution is warranted when interpreting this observation. We do not propose a causal relationship between RE and CVT on the basis of a single case. Rather, the significance of this report lies in documenting the coexistence of two uncommon neurological disorders in the same individual. As with other unrelated neurological pathologies in patients with chronic neurological disease, the association observed here may reflect concurrence rather than causation. Although chronic neuroinflammation and endothelial dysfunction could theoretically contribute to a prothrombotic environment, such a mechanism remains speculative and unsupported by current evidence. Consequently, any potential relationship should be regarded as hypothesis-generating rather than causal. Immunomodulatory therapy remains the mainstay of treatment in RE.[45] In our patient, treatment resulted in partial seizure control but failed to reverse established neurological deficits, likely reflecting irreversible cortical injury resulting from chronic inflammation and superimposed venous infarction. Surgical approaches such as hemispherectomy, which may provide seizure control in unilateral disease, are generally unsuitable in bilateral RE because of the severe functional consequences. The present report has several limitations. Most importantly, EEG correlation and histopathological confirmation were unavailable. EEG could not be obtained because of the patient’s critical condition and lack of bedside monitoring facilities, while brain biopsy was not performed because consent could not be secured. Therefore, the diagnosis relied on established clinical and neuroimaging criteria. Furthermore, the coexistence of CVT and bilateral RE should not be interpreted as evidence of a causal association. In conclusion, we report a rare case of bilateral RE associated with CVT in a young adult. The coexistence of these conditions resulted in refractory seizures, progressive cognitive decline, and substantial neurological disability despite aggressive immunotherapy. Bilateral RE should be considered in patients with progressive focal epilepsy involving both hemispheres, particularly when neuroimaging demonstrates sequential bilateral cerebral involvement. Early diagnosis and prompt immunomodulatory treatment remain essential; however, outcomes remain guarded in advanced bilateral disease complicated by vascular events. Declaration of patient consent The authors certify that they have obtained all appropriate patient consent forms. In the form, the patient(s) has given his consent for his images and other clinical information to be reported in the journal. The patient understands that his name and initials will not be published and due efforts will be made to conceal his identity, but anonymity cannot be guaranteed. Conflicts of interest There are no conflicts of interest.